|
Index of reports
> Cases resulting in other serious reactions (17)
> Cases with Erythema Multiforme (3)
Below is the selection of adverse event reports related to Keflex (Cephalexin) that includes cases resulting in other serious reactions where reactions include erythema multiforme.
Adverse event in 58 year old female receiving Keflex (Cephalexin)
Reported by a physician from United States on 2007-02-15
Patient: 58 year old female
Adverse reactions / side effects: Localised Infection, Drug Dose Omission, Application Site Reaction, Erythema Multiforme, Application Site Scab
Suspect drug(s):
Aldara
Dosage: (0.5 sachet, 5 in 1 week(s), topical
Administration route: Topical
Indication: Actinic Keratosis
Start date: 2006-01-01
End date: 2006-01-01
Aldara
Dosage: (0.5 sachet, 5 in 1 week(s), topical
Administration route: Topical
Indication: Basal Cell Carcinoma
Start date: 2006-01-01
End date: 2006-01-01
Aldara
Dosage: (0.5 sachet, 5 in 1 week(s), topical
Administration route: Topical
Indication: Actinic Keratosis
Start date: 2006-12-25
End date: 2007-01-13
Aldara
Dosage: (0.5 sachet, 5 in 1 week(s), topical
Administration route: Topical
Indication: Basal Cell Carcinoma
Start date: 2006-12-25
End date: 2007-01-13
Altace
Hydrochlorothiazide
Zetia
Folic Acid
Aspirin
Fish OIL
Keflex
Adverse event in 58 year old female receiving Keflex (Cephalexin)
Reported by a physician from United States on 2007-01-30
Patient: 58 year old female
Adverse reactions / side effects: Staphylococcal Skin Infection, Toxic Epidermal Necrolysis, Oral Mucosal Exfoliation, Eosinophilia, Fatigue, Malaise, Erythema Multiforme, Application Site Scab
Suspect drug(s):
Aldara
Dosage: (0.5 sachet, 5 in 1 week (s)), topical
Administration route: Topical
Indication: Actinic Keratosis
Start date: 2006-01-01
End date: 2006-01-01
Aldara
Dosage: (0.5 sachet, 5 in 1 week (s)), topical
Administration route: Topical
Indication: Basal Cell Carcinoma
Start date: 2006-01-01
End date: 2006-01-01
Aldara
Dosage: (0.5 sachet, 5 in 1 week (s)), topical
Administration route: Topical
Indication: Actinic Keratosis
Start date: 2006-12-25
End date: 2007-01-13
Aldara
Dosage: (0.5 sachet, 5 in 1 week (s)), topical
Administration route: Topical
Indication: Basal Cell Carcinoma
Start date: 2006-12-25
End date: 2007-01-13
Altace
Hydrochlorothiazide
Zetia
Folic Acid
Aspirin
Fish OIL
Keflex
Adverse event in 58 year old female receiving Keflex (Cephalexin)
Reported by a physician from United States on 2007-01-29
Patient: 58 year old female
Adverse reactions / side effects: Oral Intake Reduced, Drug Dose Omission, Application Site Reaction, Staphylococcal Infection, Drug Hypersensitivity, Toxic Epidermal Necrolysis, Erythema Multiforme, Herpes Zoster
Suspect drug(s):
Aldara
Dosage: 0.5 scahet, 5 in 1 weeks (s)), topical
Administration route: Topical
Indication: Actinic Keratosis
Start date: 2006-01-01
End date: 2006-01-01
Aldara
Dosage: 0.5 scahet, 5 in 1 weeks (s)), topical
Administration route: Topical
Indication: Basal Cell Carcinoma
Start date: 2006-01-01
End date: 2006-01-01
Aldara
Dosage: 0.5 scahet, 5 in 1 weeks (s)), topical
Administration route: Topical
Indication: Actinic Keratosis
Start date: 2006-12-25
End date: 2007-01-13
Aldara
Dosage: 0.5 scahet, 5 in 1 weeks (s)), topical
Administration route: Topical
Indication: Basal Cell Carcinoma
Start date: 2006-12-25
End date: 2007-01-13
Altace
Hydrochlorothiazide
Zetia
Folic Acid
Aspirin
Fish OIL
Keflex
|
